• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pactiv Evergreen Inc (NQ: PTVE )

    11.63 +0.08 (+0.69%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 196,215
    Open 11.62
    Bid (Size) 11.40 (39)
    Ask (Size) 13.98 (3)
    Prev. Close 11.55
    Today's Range 11.55 - 11.79
    52wk Range 7.140 - 15.84
    Shares Outstanding 178,277,047
    Dividend Yield 3.44%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pactiv Evergreen Inc. Successfully Reprices and Upsizes Term Loan
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    PTVE Stock Earnings: Pactiv Evergreen Beats EPS, Misses Revenue for Q1 2024
    PTVE stock results show that Pactiv Evergreen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -17.63%
    -17.63%
    1 Month
    -7.33%
    -7.33%
    3 Month
    -16.51%
    -16.51%
    6 Month
    -15.66%
    -15.66%
    1 Year
    +52.42%
    +52.42%

    More News

    Read More
    Pactiv Evergreen Reports First Quarter 2024 Financial Results
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Pactiv Evergreen Inc. Declares Quarterly Dividend
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Where Pactiv Evergreen Stands With Analysts
    Via Benzinga
    Expert Outlook: Pactiv Evergreen Through The Eyes Of 9 Analysts
    Via Benzinga
    Why Pactiv Evergreen Stock Was Falling Today
    Via The Motley Fool
    Pactiv Evergreen Inc. Schedules First Quarter 2024 Financial Results
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    These Analysts Revise Their Forecasts On Pactiv Evergreen After Q4 Results
    Via Benzinga
    AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Pactiv Evergreen: Q4 Earnings Insights
    Via Benzinga
    Pactiv Evergreen Reports Fourth Quarter 2023 Financial Results
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Earnings Preview For Pactiv Evergreen
    Via Benzinga
    5 Analysts Have This To Say About Pactiv Evergreen
    Via Benzinga
    Pactiv Evergreen Inc. Declares Quarterly Dividend
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Pactiv Evergreen Inc. Schedules Fourth Quarter 2023 Financial Results
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Pactiv Evergreen Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
    Via Benzinga
    Top 5 Materials Stocks That Are Ticking Portfolio Bombs
    Via Benzinga
    Pactiv Evergreen Releases Environmental Social Governance (ESG) Report
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Top 2 Materials Stocks You May Want To Dump This Quarter
    Via Benzinga
    Pactiv Evergreen Inc. Declares Quarterly Dividend
    From Pactiv Evergreen Inc.
    Via GlobeNewswire
    Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.